Article
Evaluating novel in silico tools for accurate pathogenicity classification in epilepsy-associated genetic missense variants.
Epilepsia - 1 Dec 2024
Montanucci Ludovica, Brünger Tobias, Boßelmann Christian M, Ivaniuk Alina, Pérez-Palma Eduardo, Lhatoo Samden, Leu Costin, Lal Dennis
Abstract excerpt
OBJECTIVE: Determining the pathogenicity of missense variants in clinical genetic tests for individuals with epilepsy is crucial for guiding personalized treatment. However, achieving a definitive pathogenic classification remains challenging, with most missense variants still classified as variants of uncertain significance (VUS) and with the availability of many computational tools which may provide conflicting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
